Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
INSTITUTE OF NEONATOLOGY BELGRADE has floated a tender for Original Biological Drug Bevacizumab. The project location is Serbia and the tender is closing on 30 Apr 2024. The tender notice number is 1629, while the TOT Ref Number is 100243485. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Serbia
Summary : Original Biological Drug Bevacizumab
Deadline : 30 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 100243485
Document Ref. No. : 1629
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : RSD 297000.00
Purchaser's Detail
Purchaser : INSTITUTE OF NEONATOLOGY BELGRADE
RS11 - Belgrade region, BELGRADE
Serbia
Email :dean.firkelj@gmail.com
Tender Details
Original biological drug Bevacizumab
Status of the procedure :- Client INSTITUTE OF NEONATOLOGY BELGRADE Client location RS11 - Belgrade region, BELGRADE
Documents
Want To Bid in This Tender?
Get Local Agent Support in Serbia and 60 More Countries.
View Tenders By
Sign in with Google